Researcher profile

Joost Nederend

Joost Nederend contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
3topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2026arXiv

Deep Learning-Based Segmentation of Peritoneal Cancer Index Regions from CT Imaging

Peritoneal metastases are currently assessed using diagnostic laparoscopy to determine Sugarbaker's Peritoneal Cancer Index (sPCI), which works by dividing the abdomen into 13 regions and scoring each region based on tumor size. A recent consensus study defined 3D regions to facilitate a radiological PCI (rPCI), providing standardized anatomical regions for imaging-based assessment. Despite its clinical value, sPCI is invasive and lacks a standardized imaging counterpart. In this study, we propose a deep learning-based approach to automatically segment the rPCI regions on CT. We evaluate nnU-Net and Swin UNETR on 62 CT scans with rPCI regions manually annotated by three clinical researchers and validated by two expert radiologists. Performance was assessed using five-fold cross-validation with the Dice Similarity Coefficient (Dice), 95th percentile Hausdorff distance and Average Surface Distance. nnU-Net achieved an overall Dice of 0.82, approaching interobserver agreement (0.88) and outperforming Swin UNETR (0.76), with remaining challenges primarily in right flank and small-bowel regions. These results demonstrate feasibility of automated rPCI segmentation, laying the foundation for non-invasive, imaging-based assessment.

preprint2022arXiv

Improved Pancreatic Tumor Detection by Utilizing Clinically-Relevant Secondary Features

Pancreatic cancer is one of the global leading causes of cancer-related deaths. Despite the success of Deep Learning in computer-aided diagnosis and detection (CAD) methods, little attention has been paid to the detection of Pancreatic Cancer. We propose a method for detecting pancreatic tumor that utilizes clinically-relevant features in the surrounding anatomical structures, thereby better aiming to exploit the radiologist's knowledge compared to other, conventional deep learning approaches. To this end, we collect a new dataset consisting of 99 cases with pancreatic ductal adenocarcinoma (PDAC) and 97 control cases without any pancreatic tumor. Due to the growth pattern of pancreatic cancer, the tumor may not be always visible as a hypodense lesion, therefore experts refer to the visibility of secondary external features that may indicate the presence of the tumor. We propose a method based on a U-Net-like Deep CNN that exploits the following external secondary features: the pancreatic duct, common bile duct and the pancreas, along with a processed CT scan. Using these features, the model segments the pancreatic tumor if it is present. This segmentation for classification and localization approach achieves a performance of 99% sensitivity (one case missed) and 99% specificity, which realizes a 5% increase in sensitivity over the previous state-of-the-art method. The model additionally provides location information with reasonable accuracy and a shorter inference time compared to previous PDAC detection methods. These results offer a significant performance improvement and highlight the importance of incorporating the knowledge of the clinical expert when developing novel CAD methods.